Record revenue and earnings headline the FY26 result
Austco Healthcare (ASX: AHC) delivered a record FY26 result, growing revenue and earnings while absorbing the full-year cost base of three acquired businesses. The clinical communications provider serves more than 5,000 facilities across 60+ countries, and its FY26 full-year results presentation, dated 27 August 2026, framed a story of expanding recurring software revenue, a strong balance sheet and a robust contracted pipeline into FY27.
Management reported revenue of $94.2m, up 15.8%, with EBITDA of $14.9m, up 14.0%. Net profit after tax (NPAT) rose 51.8% to $9.0m, while the company closed the year with $16.3m in cash and no material borrowings.
When big ASX news breaks, our subscribers know first
FY26 scorecard: record top and bottom line
The result combined record revenue and profit with gross margin expansion, while the EBITDA margin was held broadly in line with the prior year at 15.8% (FY25: 16.0%). That margin was maintained even as the group funded a full-year acquired cost base.
One nuance matters for interpreting the headline growth. On an underlying basis, excluding contingent consideration remeasurement in both years, net profit before tax (NPBT) rose 3.9% to $10.7m, and underlying NPAT of $8.1m was in line with FY25. Part of the reported earnings uplift is therefore remeasurement-driven rather than purely operational.
| Metric | FY26 | Change |
|---|---|---|
| Revenue | $94.2m | +15.8% |
| EBITDA | $14.9m | +14.0% |
| Gross Margin | 53.4% | +140bp |
| NPBT | $11.6m | +43.8% |
| NPAT | $9.0m | +51.8% |
The gross margin gains reflect supply chain efficiencies delivered through integration, with materials costs falling in absolute terms on lower input prices.
The business model: win the facility, monetise it for a decade
Austco earns revenue across three lines, each with different economics. A clinical communications system is specified into a building during the design phase, often years before construction begins, tendered once, and then earns for a decade or more through equipment, installation and recurring maintenance.
The three revenue lines are:
- Equipment (55%): $51.9m, up 12.1% — call points, in-room devices, touchscreens and location components
- Installation (33%): $31.0m, up 21.4% — configuration, integration and the low-voltage infrastructure around the systems
- Software & Maintenance (12%): $11.4m, up 19% — perpetual Tacera licences plus maintenance agreements of one to five years
The FY26 cycle lengthened, as slower construction programmes and tighter capital budgets deferred award and installation timing into later periods. Management framed these as deferred orders rather than lost work. For investors, the recurring layer is significant because it compounds independently of project timing, representing the annuity value of the installed base.
Why the recurring revenue story matters
Software and maintenance revenue grew 19% to $11.4m and accelerated through the year, with second-half revenue of $6.4m versus $5.0m in the first half, an increase of 28%. This recurring layer is higher-margin revenue earned from relationships already won, with no new customer acquisition cost.
A ten-year, $4.2m software maintenance agreement (SMA) at Jurong in Singapore commences 1 October 2026, recognised over the term at approximately $420,000 a year. It is not yet reflected in FY26 numbers.
The Jurong contract win was the third milestone at the same Singapore facility, converting an existing Tacera installed base into a decade of recurring service income rather than requiring a new customer sale.
Contract wins reinforce the global platform
Flagship wins across three regions reinforced Austco’s global platform during the period. Management emphasised the reference-site value of Hospital Israelita Albert Einstein, ranked the number one hospital in Latin America and among the top 20 globally, positioned as a flagship platform for further growth across the region. The Einstein contract was won on the strength of relationship and solution quality, while the Warrnambool Base Hospital contract was won on cost and integration.
| Contract | Location | Value | Detail |
|---|---|---|---|
| Hospital Israelita Albert Einstein | São Paulo, Brazil | $1.85m Phase 1 POs | Full Tacera IP retrofit; Phase 2 order expected H1 next year |
| Warrnambool Base Hospital | Victoria, Australia | $1.1m | Tacera + Pulse Mobile; part of $396.1m redevelopment |
| Jurong / Ng Teng Fong | Singapore | $4.2m 10-yr SMA | Won 2023, extended 2024, converted to a decade of SMA July 2026 |
Geographic mix shifts to ANZ as acquisitions land
The regional mix shifted towards Australia and New Zealand (ANZ), which now represents 56% of Group revenue following the G&S Technologies acquisition and public hospital and aged care programmes. Asia and Europe were softer on installation timing, which management framed as deferred rather than lost, with Asia now contracted for ten years at Jurong from October 2026.
North America delivered growth, although tariff-related supply-chain uncertainty influenced decision timing.
- ANZ: $52.8m, up 38.1% (56% of revenue)
- North America: $30.4m, up 11.0% (32% of revenue)
- Asia: $6.7m, down versus a strong FY25 on installation timing
- Europe: $4.4m, down versus FY25 on timing and foreign exchange
Balance sheet strength and contracted revenue support the outlook
Cash grew to $16.3m despite the payment of a $6.0m earn-out during the year, supported by operating cash flow of $12.5m. The company reported net assets of $62.1m and no material borrowings.
Unfilled contracted revenue (UCR), which is contracted revenue awaiting delivery and installation conversion, stood at $51.2m at 17 August 2026, up 13% since June. Management attributed the movement to new awards, with a year-end foreign exchange effect reflecting currency translation rather than lost work.
UCR by revenue type breaks down as follows:
- Equipment: $17.6m
- Installation: $20.9m
- SMA: $9.0m
- Software: $3.6m
Austco enters FY27 with a healthy sales pipeline, momentum across all regions, and $51.2 million of unfilled contracted revenue at 17 August 2026.
Structural tailwinds and the AI roadmap
The result sits against structural demand drivers including ageing populations, healthcare digitalisation and tightening compliance requirements. Management cited global digital health spending forecast to grow from US$389bn in 2024 to US$1.9tn by 2031, a compound rate of 25.7%, while the population aged 65 and over is projected to rise from 703m in 2024 to 1.5bn by 2050.
The presentation detailed an AI roadmap positioned to extend the Tacera, Pulse and RTLS platforms across predictive clinical intelligence, intelligent workflow optimisation and predictive maintenance. Foundations are already live in Pulse Insights, with the broader AI layer described as a roadmap rather than a fully deployed suite.
Austco invested $4.8m in the Tacera platform in FY26. Management framed AI as a means of deepening platform stickiness and expanding recurring software revenue, reinforcing competitive differentiation.
Disciplined M&A: four acquisitions, one formula
The acquisition of Medical Communications Systems (MCS) in South Australia continued a consistent M&A playbook. MCS was acquired at 3.5× normalised EBITDA for total consideration of approximately $2.88m, adding $1.88m of net revenue and $0.82m of EBITDA on a full-year basis, having been a reseller for 15 years since 2011.
The MCS acquisition terms include $2.24 million payable upfront from existing cash and a $0.64 million performance-linked earnout, a structure consistent with the earn-out discipline Austco applied across Teknocorp, Amentco, and G&S Technologies before it.
MCS generated approximately $3.33m of FY26 revenue, of which $1.45m was already recorded as Austco product and software revenue, which is why the net revenue added is lower. The earn-out structure works in both directions: Amentco settled above the recognised amount ($8.4m versus $5.9m), while G&S was revised down. Across three years, four reseller acquisitions have been completed at conservative multiples, funded from operating cash flow, with performance-based earn-outs aligning vendors to delivery.
Don’t Miss the Next Healthcare Breakout on the ASX
Big News Blast delivers breaking ASX healthcare news directly to your inbox within minutes of release, complete with in-depth analysis. Join 20,000+ investors already staying ahead of the market at no cost. Click the “Free Alerts” button at Big News Blast to start receiving FREE alerts the moment ASX healthcare announcements drop.